|
|
J Clin Microbiol. 1994 December; 32(12): 2999–3001. | PMCID: PMC264214 |
Use of cephalexin-aztreonam-arabinose agar for selective isolation of Enterococcus faecium. M Ford, J D Perry, and F K Gould Microbiology Department, Freeman Hospital, High Heaton, Newcastle upon Tyne, United Kingdom. Abstract Cephalexin-aztreonam-arabinose agar (CAA), a new selective agar, was examined in comparison with nalidixic acid-colistin agar for the differentiation of Enterococcus faecium from other enterococci and the ability to isolate the organism from feces. Two hundred sixteen enterococcus isolates and a variety of gram-positive and gram-negative control strains were inoculated onto both media. All control strains of E. faecium were easily differentiated from Enterococcus faecalis and Enterococcus durans on the basis of arabinose fermentation on CAA. Differentiation of E. faecium from other enterococci or Streptococcus bovis was not possible on nalidixic acid-colistin agar. Increased isolation of E. faecium was demonstrated on CAA when both media were compared for the isolation of the organism from feces. CAA has been shown to possess excellent differential and selective features allowing the simple and effective isolation of E. faecium from heavily contaminated sites. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (547K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. Images in this article Click on the image to see a larger version. These references are in PubMed. This may not be the complete list of references from this article. - Boyce JM, Opal SM, Potter-Bynoe G, LaForge RG, Zervos MJ, Furtado G, Victor G, Medeiros AA. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother. 1992 May;36(5):1032–1039. [PubMed]
- Courvalin P. Resistance of enterococci to glycopeptides. Antimicrob Agents Chemother. 1990 Dec;34(12):2291–2296. [PubMed]
- Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989 Apr;27(4):731–734. [PubMed]
- Gray JW, Pedler SJ. Antibiotic-resistant enterococci. J Hosp Infect. 1992 May;21(1):1–14. [PubMed]
- Herman DJ, Gerding DN. Antimicrobial resistance among enterococci. Antimicrob Agents Chemother. 1991 Jan;35(1):1–4. [PubMed]
- Livornese LL, Jr, Dias S, Samel C, Romanowski B, Taylor S, May P, Pitsakis P, Woods G, Kaye D, Levison ME, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992 Jul 15;117(2):112–116. [PubMed]
- Noble CJ. Carriage of group D streptococci in the human bowel. J Clin Pathol. 1978 Dec;31(12):1182–1186. [PubMed]
- Ruoff KL, de la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ. Species identities of enterococci isolated from clinical specimens. J Clin Microbiol. 1990 Mar;28(3):435–437. [PubMed]
- Uttley AH, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AJ, Fitch LE, Heptonstall J. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect. 1989 Aug;103(1):173–181. [PubMed]
- Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med. 1987 May;106(5):687–691. [PubMed]
|